Grab This Bargain Even Cheaper Than Director Gannon Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 19, Fusion Pharmaceuticals Inc's Director, Steven Gannon, invested $25,526.55 into 3,171 shares of FUSN, for a cost per share of $8.05..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.